Immunotherapy for Head and Neck Squamous Cell Carcinoma.
Curr Oral Health Rep
; 3(2): 74-81, 2016 Jun.
Article
em En
| MEDLINE
| ID: mdl-27398287
ABSTRACT
Head and neck squamous cell carcinoma has been found to be an immunosuppressive malignancy, with many defects in the host immune system contributing to the progression of disease. A greater understanding of these defects has lead to the identification and investigation of new therapeutic strategies, targeting immune system dysfunction in an effort to improve the outcomes of this disease. This article provides a brief review of the knowledge regarding the immune defects present in head and neck cancer, as well as a review of the current therapeutic strategies being investigated for use.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Curr Oral Health Rep
Ano de publicação:
2016
Tipo de documento:
Article